Kimberly-Clark to buy maker of Tylenol
Digest more
Irving-based Kimberly-Clark announced a blockbuster deal Monday morning to acquire consumer health care company Kenvue for nearly $50 billion. Here are
Not long after President Trump made his statement, Kenvue and Johnson & Johnson got into another complicated legal mess when the Republican state of Texas sued them. The complaint says that the companies didn’t tell people about the possible risks of taking acetaminophen while pregnant.
Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health goods company.